Writing Intervention With Adolescents and Young Adults With Cancer
Launched by ST. JUDE CHILDREN'S RESEARCH HOSPITAL · Jul 27, 2023
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how creative writing activities can help teenagers and young adults with cancer. Researchers at St. Jude Children's Research Hospital want to find out if these young patients would be interested in participating in writing exercises and if they believe these activities can improve their well-being during their treatment. The goal is to understand whether this type of writing program is something that could be valuable for them.
To be eligible for the study, participants should be between 15 and 25 years old and currently receiving treatment for cancer at St. Jude. Parents of patients who have passed away from cancer may also participate if their child was part of a previous study. Those who join the trial can expect to engage in writing exercises that allow them to express their thoughts and feelings about their experiences with cancer. This study is currently open for recruitment, and participants will help researchers learn more about the benefits of writing as a supportive tool for young people facing cancer.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 15-25
- • Currently receiving cancer-directed therapy
- • Active patient at St. Jude Children's Research Hospital
- • Parent of a ChronCan participant who has passed away
- Exclusion Criteria:
- • Does not meet the inclusion criteria
- • If the parents have not responded or not interviewed till December 31, 2025.
About St. Jude Children's Research Hospital
St. Jude Children's Research Hospital is a premier pediatric research institution dedicated to advancing the treatment and understanding of catastrophic diseases in children, particularly cancer and other life-threatening conditions. Renowned for its innovative clinical trials and cutting-edge research, St. Jude integrates patient care with scientific discovery to develop new therapies and improve outcomes for young patients. The hospital is committed to ensuring that no family receives a bill for treatment, travel, housing, or food, fostering a holistic approach to pediatric care. Through collaboration with global research networks, St. Jude aims to share its findings and expertise to enhance treatment options worldwide, making significant strides in pediatric medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Memphis, Tennessee, United States
Patients applied
Trial Officials
Trisha K. Paul, MD
Principal Investigator
St. Jude Children's Research Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported